About 100 university experts and scholars from China and around the world gathered at Peking University PKU on Wednesday advocating for more cooper ...
With a growing portfolio in an attractive rare-disease niche—and acceleration of profit growth beginning in 2022—BioMarin could be an acquisition target for pharmaceutical firms with pipelines to fill ...
China's economy is still struggling to recover from the pandemic, nearly two years after Beijing dropped its draconian zero-COVID lockdowns. In the first three quarters of 2024, economic growth came ...
From keynote speeches to daily conversations by grassroots members, many easy-to-understand phrases are used by the leadership to explicate the effort and call for more: "Take out tigers," "swat flies ...
The National PKU Alliance (NPKUA), in collaboration with a coalition of PKU-related patient advocacy organizations, announces the TruePKU initiative, a groundbreaking effort to highlight the lived ...